Zepp Health Corporation Sponsored ADR (NYSE:ZEPP – Get Free Report) saw a large drop in short interest in the month of January. As of January 30th, there was short interest totaling 357,811 shares, a drop of 31.2% from the January 15th total of 520,263 shares. Currently, 3.9% of the company’s stock are short sold. Based on an average daily volume of 118,750 shares, the days-to-cover ratio is presently 3.0 days. Based on an average daily volume of 118,750 shares, the days-to-cover ratio is presently 3.0 days. Currently, 3.9% of the company’s stock are short sold.
Wall Street Analyst Weigh In
Several equities analysts have commented on the company. Fundamental Research set a $64.37 price objective on Zepp Health and gave the company a “buy” rating in a research report on Tuesday, November 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Zepp Health in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Zepp Health presently has a consensus rating of “Hold” and a consensus price target of $64.37.
Get Our Latest Analysis on Zepp Health
Zepp Health Stock Down 3.4%
Zepp Health (NYSE:ZEPP – Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($0.04) earnings per share for the quarter. The company had revenue of $75.79 million for the quarter. Zepp Health had a negative net margin of 28.28% and a negative return on equity of 21.45%.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the company. Public Employees Retirement System of Ohio bought a new stake in shares of Zepp Health in the third quarter worth $43,000. Dimensional Fund Advisors LP bought a new position in Zepp Health in the fourth quarter valued at about $241,000. Oasis Management Co Ltd. purchased a new position in Zepp Health in the third quarter worth about $276,000. Capstone Capital Management Ltd bought a new stake in shares of Zepp Health during the 4th quarter valued at about $298,000. Finally, Themes Management Co LLC purchased a new stake in shares of Zepp Health during the 4th quarter valued at about $489,000. Institutional investors own 52.61% of the company’s stock.
Zepp Health Company Profile
Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.
At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.
Read More
- Five stocks we like better than Zepp Health
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Did you hear what Nvidia’s CEO said?
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
